Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Total Debt (2019 - 2020)

aTYR PHARMA (ATYR) has disclosed Total Debt for 2 consecutive years, with $3.1 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Total Debt fell 71.08% year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Sep 2020, down 71.08%, and an annual FY2019 reading of $8.7 million, changed N/A over the prior year.
  • Total Debt was $3.1 million for Q3 2020 at aTYR PHARMA, down from $5.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $14.2 million in Q1 2019 and bottomed at $3.1 million in Q3 2020.